| NOZAC ΤΑΒ 5MG/ΤΑΒ (BT x 28) |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
| NOZAC ΤΑΒ 5MG/ΤΑΒ (BT x 28) |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |